These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7542147)
1. Antenatal screening for neural tube defects. Smith L Mod Midwife; 1995 Jul; 5(7):27-9. PubMed ID: 7542147 [No Abstract] [Full Text] [Related]
2. Maternal serum screening for neural tube defects and Down syndrome. Keith D Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964 [No Abstract] [Full Text] [Related]
3. Screening for open neural tube defects from 21 to 25 weeks' gestation: the Manitoba experience. Björklund NK; MacDonald KM; Evans JA; Schneider CE; Chodirker BN Prenat Diagn; 2005 Aug; 25(8):715-7. PubMed ID: 16052469 [No Abstract] [Full Text] [Related]
4. [Screening of pregnant women for fetal neural tube defects by determination of the serum alpha fetoprotein level]. Los FJ; Hagenaars AM; Huisjes HJ; de Bruyn HW; Ruitenberg EJ Ned Tijdschr Geneeskd; 1980 Jul; 124(27):1096-101. PubMed ID: 6157115 [No Abstract] [Full Text] [Related]
5. Screening for fetal neural tube defects: rationale and experience. Brock DJ Prog Clin Biol Res; 1982; 103 Pt B():461-72. PubMed ID: 6187021 [No Abstract] [Full Text] [Related]
6. [Alpha-fetoproteins in obstetrics]. Weitzel H Gynakologe; 1983 Sep; 16(3):148-54. PubMed ID: 6196260 [No Abstract] [Full Text] [Related]
7. [Prenatal screening for fetal neural-tube defects by immunodiffusion autoradiography (author's transl)]. Zheng ZQ Zhonghua Fu Chan Ke Za Zhi; 1981 Oct; 16(4):209-10. PubMed ID: 6177478 [No Abstract] [Full Text] [Related]
10. [Multiple of the median and its uses in antenatal screening]. Jiangsu Province Birth Planning Commitee Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334 [No Abstract] [Full Text] [Related]
13. Criticism of the California alpha fetoprotein screening program. Lasnover AL West J Med; 1987 Jan; 146(1):100. PubMed ID: 2435065 [No Abstract] [Full Text] [Related]
14. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)]. Thix J Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823 [TBL] [Abstract][Full Text] [Related]
15. Maternal serum screening of Palestinian women in the West Bank. Husseini A; Akkawi M East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399 [TBL] [Abstract][Full Text] [Related]
16. [Serum AFP determination in pregnant women]. Huisjes HJ; de Bruijn HW; Ruitenberg EJ Ned Tijdschr Geneeskd; 1981 Sep; 125(37):1500-1. PubMed ID: 6170001 [No Abstract] [Full Text] [Related]
17. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis. Jørgensen FS Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264 [No Abstract] [Full Text] [Related]
18. Screening for neural tube defects. Results in practice. Hibbard BM Midwife Health Visit Community Nurse; 1982 Nov; 18(11):460-6. PubMed ID: 6183562 [No Abstract] [Full Text] [Related]
19. Using automated prenatal screening assays in the clinical laboratory. Blacklaw M Am Clin Lab; 2000; 19(1):14. PubMed ID: 10848433 [No Abstract] [Full Text] [Related]
20. Screening for neural tube defects. Drugan A; Weissman A; Evans MI Clin Perinatol; 2001 Jun; 28(2):279-87, vii. PubMed ID: 11499052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]